Company: XOMAP
Filing Date: 2025-10-03
Form Type: 424B5
Source: 0001193125-25-230393
Chunk: 54

Company: XOMA Royalty Corp
Filing Date: 2025-10-03
Form: 424B5
Chunk 54
---
 authorized no one to provide you with any information that differs from that contained in this prospectus supplement. Accordingly, we take no responsibility for any other information
that others may give you. You should not assume that the information in this prospectus supplement is accurate as of any date other than the date of the front cover of this prospectus supplement.

S-41

PROSPECTUS

$200,000,000

### COMMON STOCK

### PREFERRED
STOCK

### DEPOSITARY SHARES

### DEBT SECURITIES

### WARRANTS

### SUBSCRIPTION RIGHTS

### CONTINGENT VALUE RIGHTS

### ROYALTY CERTIFICATES
UNITS

From time to time, we may issue, in one or more series or classes, up to $200,000,000 in aggregate principal amount of our common stock, preferred stock,
depositary shares, debt securities, warrants, subscription rights, contingent value rights, royalty certificates and/or units consisting of the foregoing, at prices and on terms that we will determine at the time of the offering.

This prospectus provides you with a general description of the securities we may offer. Each time we offer securities, we will provide specific terms of the
securities offered in a supplement to this prospectus. We may also authorize one or more free writing prospectuses to be provided to you in connection with these offerings. The prospectus supplement and any related free writing prospectus may also
add, update or change information contained in this prospectus. We may not sell any securities under this prospectus without delivery of the applicable prospectus supplement. If information in any prospectus supplement is inconsistent with the
information in this prospectus, then the information in that prospectus supplement will apply and will supersede the information in this prospectus.

We may
sell the securities directly to you, through agents we select, or through underwriters and dealers we select. If agents, underwriters or dealers are used to sell the securities, we will name them and describe their compensation in a prospectus
supplement or sales agreement prospectus. Each prospectus supplement will provide the amount, price, terms and plan of distribution relating to the securities to be sold pursuant to such prospectus supplement.

You should read this prospectus, the applicable prospectus supplement and any related free writing prospectus carefully, as well as any documents incorporated
by reference, before you invest in any of the securities being offered.

Our common stock, $0.0075 par value, is listed on The Nasdaq